Literature DB >> 15695664

Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens.

Jill S Huppert1, Byron E Batteiger, Phillip Braslins, James A Feldman, Marcia M Hobbs, Heather Z Sankey, Arlene C Sena, Karen A Wendel.   

Abstract

Trichomonas vaginalis infection is estimated to be the most widely prevalent nonviral sexually transmitted infection in the world. Wet-mount microscopy is the most common diagnostic method, although it is less sensitive than culture. The OSOM Trichomonas Rapid Test (Genzyme Diagnostics, Cambridge, Mass.) (referred to here as OSOM) is a new point-of-care diagnostic assay for T. vaginalis that uses an immunochromatographic capillary flow (dipstick) assay and provides results in 10 min. The purpose of this study was to determine the test characteristics of OSOM compared to those of a composite reference standard (CRS) comprised of wet-mount microscopy and T. vaginalis culture. This multicenter cross-sectional study enrolled sexually active women > or =18 years of age who presented with symptoms of vaginitis, exposure to T. vaginalis, or multiple sexual partners. Vaginal-swab specimens were obtained for T. vaginalis culture, wet mount, and rapid testing. The prevalence of T. vaginalis in this sample was 23.4% (105 of 449) by the CRS. The sensitivity and specificity of OSOM vaginal-swab specimens were 83.3 and 98.8%, respectively, while wet mount had a sensitivity and specificity of 71.4 and 100%, respectively, compared to the CRS. OSOM performed significantly better than wet mount (P = 0.004) and detected T. vaginalis in samples that required 48 to 72 h of incubation prior to becoming culture positive. The performance of the rapid test was not affected by the presence of coinfections with chlamydia and gonorrhea. The OSOM Trichomonas Rapid Test is a simple, objective test that can be expected to improve the diagnosis of T. vaginalis, especially where microscopy and culture are unavailable.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695664      PMCID: PMC548056          DOI: 10.1128/JCM.43.2.684-687.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions.

Authors:  F J Bowden; G P Garnett
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

2.  Assessment of a rapid antigen detection system for Trichomonas vaginalis infection.

Authors:  G A Miller; J D Klausner; T J Coates; R Meza; C A Gaydos; J Hardick; S Leon; C F Caceres
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

3.  Interactions between STDs and HIV infection.

Authors:  M Laga
Journal:  STD Bull       Date:  1992

4.  Trichomonas vaginalis as a cause of urethritis in Malawian men.

Authors:  M M Hobbs; P Kazembe; A W Reed; W C Miller; E Nkata; D Zimba; C C Daly; H Chakraborty; M S Cohen; I Hoffman
Journal:  Sex Transm Dis       Date:  1999-08       Impact factor: 2.830

5.  The epidemiology of trichomoniasis in women in four African cities.

Authors:  A Buvé; H A Weiss; M Laga; E Van Dyck; R Musonda; L Zekeng; M Kahindo; S Anagonou; L Morison; N J Robinson; R J Hayes
Journal:  AIDS       Date:  2001-08       Impact factor: 4.177

6.  Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.

Authors:  Prashini Moodley; David Wilkinson; Cathy Connolly; Jack Moodley; A Willem Sturm
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

7.  Gynaecological infections as risk determinants of subsequent cervical neoplasia.

Authors:  M Viikki; E Pukkala; P Nieminen; M Hakama
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

8.  A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis.

Authors:  W Wiese; S R Patel; S C Patel; C A Ohl; C A Estrada
Journal:  Am J Med       Date:  2000-03       Impact factor: 4.965

9.  'Shelf life' of Trichomonas vaginalis.

Authors:  M A Kingston; D Bansal; E M Carlin
Journal:  Int J STD AIDS       Date:  2003-01       Impact factor: 1.359

10.  Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.

Authors:  Hillard Weinstock; Stuart Berman; Willard Cates
Journal:  Perspect Sex Reprod Health       Date:  2004 Jan-Feb
View more
  28 in total

1.  Suboptimal Trichomonas vaginalis Antigen Test Performance in a Low-Prevalence Sexually Transmitted Infection Community.

Authors:  Kimber L Munson; Maureen Napierala; Erik Munson
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

2.  Testing for sexually transmitted infections: a brave new world?

Authors:  R W Peeling
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

3.  Diagnosing Vaginal Infections: It's Time to Join the 21st Century.

Authors:  Barbara Van Der Pol
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.725

4.  Performance of a rapid self-test for detection of Trichomonas vaginalis in South Africa and Brazil.

Authors:  Heidi E Jones; Sheri A Lippman; Helio H Caiaffa-Filho; Taryn Young; Janneke H H M van de Wijgert
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

5.  Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial.

Authors:  Jane R Schwebke; Marcia M Hobbs; Stephanie N Taylor; Arlene C Sena; Michael G Catania; Barbara S Weinbaum; Ann D Johnson; Damon K Getman; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

Review 6.  Trichomoniasis: evaluation to execution.

Authors:  Djana F Harp; Indrajit Chowdhury
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-03-25       Impact factor: 2.435

7.  Stepwise diagnosis of Trichomonas vaginalis infection in adolescent women.

Authors:  Lucia Pattullo; Sarah Griffeth; Lili Ding; Joel Mortensen; Jennifer Reed; Jessica Kahn; Jill Huppert
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

8.  Abnormal vaginal pH and Mycoplasma genitalium infection.

Authors:  Jill S Huppert; Justin R Bates; Akilah F Weber; Nicole Quinn; Charlotte A Gaydos
Journal:  J Pediatr Adolesc Gynecol       Date:  2012-11-15       Impact factor: 1.814

9.  Correlation of leukorrhea and Trichomonas vaginalis infection.

Authors:  Gweneth B Lazenby; David E Soper; Frederick S Nolte
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

10.  Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.

Authors:  Jill S Huppert; Bin Huang; Chen Chen; Hassan Y Dawood; Raina N Fichorova
Journal:  J Infect Dis       Date:  2013-01-25       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.